Live tape
Top 8, mentions 7d15,592MSFT3,079 mentions▲ +0.09GOOGL2,150 mentions▲ +0.05AAPL2,109 mentions▲ +0.07META2,077 mentions▲ +0.04SNDK1,822 mentions▲ +0.06NVDA1,592 mentions▲ +0.07SPCX1,541 mentions▲ +0.06QQQ1,222 mentions▲ +0.04

Equity · Healthcare

ZLAB

Zai Lab Limited · NasdaqGM

$20.00 −3.66% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of ZLAB over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $21.22 on 4 May 2026 through $20.00 on 17 July 2026. Finazon · prior-day close.

Market cap $22.1B
52-week range $16.32 – $40.56
Avg volume 212.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

ZLAB insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Jul 2026
Open-market buys 1
Open-market sells 10
Net sold $4.83M
Non-trade filings 24
Date Insider Type Shares Value
01 Jul 2026 GAYNOR RICHARD Director Buy 1,736 $33K
30 Jun 2026 Du Ying Chairperson & CEO Sell 7,026 $130K
26 Jun 2026 Chen Yajing Chief Financial Officer Sell 2,264 $40K
26 Jun 2026 Du Ying Chairperson & CEO Sell 24,543 $429K
26 Jun 2026 Edmondson Frazor Titus III Chief Legal Officer Sell 4,103 $72K

Showing the 12 most recent of 35 filings in this window. The figures above count all of them.

Compensation mechanics (7 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Jul 2026 Du Ying Chairperson & CEO Option exercise 11,048
02 Jul 2026 Du Ying Chairperson & CEO Tax withheld 4,348 $83K
01 Jul 2026 Du Ying Chairperson & CEO Option exercise 18,000
01 Jul 2026 Du Ying Chairperson & CEO Tax withheld 7,083 $136K
29 Jun 2026 Du Ying Chairperson & CEO Option exercise 17,970
25 Jun 2026 Chen Yajing Chief Financial Officer Option exercise 6,250
25 Jun 2026 Du Ying Chairperson & CEO Option exercise 58,800

ZLAB reported financials

SEC EDGAR XBRL

ZLAB reported revenue of $457.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$175.5M.

Figure Reported Period
Revenue $457.2M 31 Dec 2025 fiscal year
Net income −$175.5M 31 Dec 2025 fiscal year
Diluted EPS −$0.16 31 Dec 2025 fiscal year
Total assets $1.1B 31 Mar 2026 at period end
Total equity $662.0M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

ZLAB earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.05 $100M
31 Dec 2025 FY 2025 $-0.16 $460M
30 Sep 2025 Q3 2025 $-0.03 $116M
30 Jun 2025 Q2 2025 $-0.04 $110M

Reported figures & scheduled dates · SEC EDGAR filings

ZLAB institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a ZLAB position for the quarter ended 31 Mar 2026 — a combined $39.7M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Citadel Advisors Held (±25%) +0.0% shares 1,688,632 $31.8M
Two Sigma Investments Added +949.1% shares 309,723 $5.8M
D. E. Shaw & Co. Trimmed −73.5% shares 63,243 $1.2M
Point72 Asset Management New position 35,120 $661K
Renaissance Technologies New position 14,300 $269K
Marshall Wace Exited

Source: SEC EDGAR 13F filings

ZLAB fails-to-deliver

SEC CNS data

On 25 Jun 2026, 55,662 shares of ZLAB failed to deliver (about $1.0M).

Settlement date Shares failed Notional % of shares out
25 Jun 2026 55,662 $1.0M 0.063%
22 Jun 2026 5,400 $98K 0.006%
18 Jun 2026 200 $4K <0.001%
17 Jun 2026 6,989 $124K 0.008%
16 Jun 2026 197 $3K <0.001%

Source: SEC fails-to-deliver (CNS) data